CYIOS Corporation (CYIO) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of CYIOS Corporation $0.00, price $0.00, upside +40.0%, quality 41 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch CYIOS Corporation for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
CYIOS Corporation operates as a holding company that engages in building, acquiring, and operating businesses across medical supplies, technology, and fintech industries. The company, through its subsidiary, delivers products to healthcare providers. CYIOS Corporation was founded in 1997 and is based in Deerfield Beach, Florida.
Stock analysis
CYIOS Corporation (CYIO) currently trades at $0.0005, while our model-based Fair Value estimate is $0.0007, implying the stock looks roughly 28.6% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $0.0009 per share, and 5 of the 7 models we run sit above the $0.0005 price.
Bear case: the Multiples group reads lowest at $0.0003, and 2 of the 7 models stay below the price. Evidence for this calculation is low.
Quality & growth
The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
CYIOS Corporation reported revenue of $11.9M in FY2025 versus $744K in FY2021, a compound +100.0%/yr. Reported net income was $497K in FY2025.
Key figures
Market cap $473K · P/S ratio 0.32 · Net margin 4.2% · Return on equity −17.9% · Return on assets (EBIT) −48.2% · Operating margin −14.7% · Revenue growth (YoY) −49.7% · Free cash flow −$401K.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).
What moves the price
The share trades about 90% below its 52-week high and at its 52-week low.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at 40%, CYIO screens cheaper than that median.
Fair Value models
Bear $0.0007Fair Value $0.0007Bull $0.0007
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.50/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+48.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+389.3%
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+9.3%
’04
’05
’06
’07
’08
’09
’10
’11
’21
’22
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1,827.4% (2020) → 0.3% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 241 stocks
Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score41 · Bottom 25%
Fair Value upside+40.0% · Top 25%
Profitability
Return on equity (TTM)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets−12.3% · Bottom 25%
Net margin (TTM)−4.1% · Bottom 25%
Operating margin (TTM)−14.7% · Bottom 25%
Growth and dividend
Revenue growth−49.7% · Bottom 25%
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM)0.32× · Cheapest 25%
EV/EBITDA12.3× · Pricier than median
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)87· sector 33
FUTURE (revenue growth)0· sector 29
PAST (return on equity)0· sector 32
HEALTH (low debt)0· sector 89
DIVIDEND (yield)0· sector 38
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "CYIOS Corporation Fair Value". https://www.fairvalue-calculator.com/stock/CYIO
Frequently asked questions
Is CYIOS Corporation (CYIO) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of $0.0007 versus a price of $0.0005, about +40% upside (undervalued).
What is the fair value of CYIO?
Our model-based fair value for CYIOS Corporation is $0.0007 (as of Sep 27, 2026), built from audited fundamentals. The current price: $0.0005.
What is the quality score of CYIO?
CYIOS Corporation has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CYIOS Corporation (CYIO)?
Our model-based price target is the fair value of $0.0007 (as of Sep 27, 2026) from 7 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the CYIOS Corporation stock forecast for 2026?
Our models put fair value at $0.0007, about +40% upside versus a price of $0.0005 (undervalued). The calculation is refreshed regularly with new filings.
What is the intrinsic value of CYIOS Corporation (CYIO)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CYIOS Corporation it is $0.0007 per share (as of Sep 27, 2026), against a price of $0.0005. It is the blended result of 7 valuation models (cash flow, earnings, asset, dividend).
Is CYIOS Corporation stock overvalued or undervalued in 2026?
As of Sep 27, 2026, CYIO trades below its calculated fair value: price $0.0005, fair value $0.0007, a gap of about +40% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CYIO?
No. The price is what the market pays today ($0.0005); the fair value is what the company's own numbers justify ($0.0007). For CYIOS Corporation the two are $0.0002 per share apart. That gap is exactly why we show both numbers side by side.
How much is CYIOS Corporation worth?
The market values CYIOS Corporation at about $473K (market capitalisation, as of Sep 27, 2026). Per share that is $0.0005; our models calculate a fair value of $0.0007 per share.
How solid is the balance sheet of CYIOS Corporation (CYIO)?
Balance-sheet figures for CYIOS Corporation (as of Sep 27, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is CYIO from its 52-week high?
CYIOS Corporation trades at $0.0005, about 90% below its 52-week high of $0.0050 and at the low of $0.0005 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0007 is for.
Which stocks are comparable to CYIOS Corporation?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Dr. Sulaiman Al Habib Medical Services Group, Tenet Healthcare Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CYIOS Corporation stock attractive at the current price?
The data as of Sep 27, 2026: price $0.0005, calculated fair value $0.0007 (+40%), Quality Score 41/100, from 7 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CYIO calculated?
We run CYIOS Corporation through 7 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0007, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1 % above its aggregate fair value. CYIOS Corporation currently trades 29 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CYIOS Corporation (CYIO)?
The closing price on Oct 1, 2026 was $0.0005. Our model-based fair value is $0.0007, about +40% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CYIOS Corporation right now?
The large discount to fair value meets weak quality (41/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($0.0007). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
Key figures of CYIOS Corporation
How large is the market capitalisation of CYIOS Corporation (CYIO)?
The market capitalisation of CYIOS Corporation is $473K. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CYIOS Corporation (CYIO)?
The price-to-sales ratio of CYIOS Corporation is 0.32 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of CYIOS Corporation (CYIO)?
The net margin of CYIOS Corporation is 4.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of CYIOS Corporation (CYIO)?
The return on equity (ROE) of CYIOS Corporation is −17.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of CYIOS Corporation (CYIO)?
On an EBIT basis the return on assets of CYIOS Corporation is −48.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of CYIOS Corporation (CYIO)?
The operating margin of CYIOS Corporation is −14.7% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at CYIOS Corporation (CYIO)?
Revenue at CYIOS Corporation is growing −49.7% versus a year earlier (3y avg +389%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does CYIOS Corporation (CYIO) generate?
The free cash flow of CYIOS Corporation is −$401K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does CYIOS Corporation (CYIO) carry?
The net debt of CYIOS Corporation is $2.1M (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch CYIOS Corporation in the live analysis
One click puts CYIOS Corporation on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 27, 2026